Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMortgage Advice Bureau Regulatory News (MAB1)

Share Price Information for Mortgage Advice Bureau (MAB1)

Share Price is delayed by 15 minutes
Get Live Data
535.00    10.00 (1.90%)
Bid:
531.00
Ask:
535.00
Spread: 4.00 (0.753%)
Market Cap: £307.86m
MAB1 Live PriceLast checked at - London Stock Exchange

Intraday Mortgage Advice Bureau Share Chart

AGM Statement

22 May 2024 07:00

RNS Number : 3902P
Mortgage Advice Bureau (Hldgs) PLC
22 May 2024
 

22 May 2024

Mortgage Advice Bureau (Holdings) plc ("MAB" or "the Group")

AGM Statement

Mortgage Advice Bureau (Holdings) plc (AIM:MAB1.L) will hold its Annual General Meeting at 1pm today during which the Non-Executive Chair, Katherine Innes Ker, will make the following statement:

"New mortgage applications in the market have been better year to date compared to the equivalent period last year. All purchase-related activity has picked up, including a welcome recovery in Buy-to-Let, whilst re-mortgaging is slightly down versus last year. This reflects a reduced number of borrowers needing to re-finance during the period, plus a greater proportion of those that have re-financed selecting Product Transfers instead. MAB has performed well in these conditions.

"In terms of completions, as expected, the wider market was slow in Q1 2024, having carried a low pipeline into this year. This resulted in a 13% reduction in new mortgage lending2 for Q1 2024 compared to the prior year. Despite these slower market conditions, we have continued to grow our market share, with MAB's total mortgage completions for Q1 2024 broadly stable at £5.7bn (2023: £5.8bn). This has been achieved, in part, through increased productivity across our adviser base. Our new mortgage completions were £4.1bn (2023: £4.4bn) with the balance of £1.6bn (2023: £1.4bn) being Product Transfers.

"On 17 May 2024, our mainstream Adviser numbers were 1,906 (31 December 2023: 1,918) and our total1 number of Advisers was 2,110 (31 December 2023: 2,158). The momentum in our new Appointed Representative ("AR") recruitment activity continues to be strong, and consequently we expect a high number of new firms and advisers to join MAB over the next few months. Our pipeline of incoming new ARs has also continued to grow strongly over the last few months. This momentum has built as a direct result of the significant developments in technology and lead generation that we have delivered, as well as further investment in our recruitment resources to ensure we can capitalise on the opportunity our proposition enhancements bring.

"We expect our existing AR firms to start growing their adviser numbers again later in the year, most likely as consumer confidence improves when there is more certainty around the outlook for mortgage interest rates and our firms can plan with a greater degree of certainty.

"MAB's performance, even though mortgage activity as a result of the subdued market conditions remains below long-term averages, is in line with the Board's expectations, with further improvement expected in the second half of this year. I am therefore delighted to be leaving MAB in excellent shape as I hand over to Mike Jones who will succeed me as Chair with effect from today. "

Peter Brodnicki, Chief Executive Officer, commented:

"Our performance once again demonstrates MAB's ability to continue winning market share in all market conditions. I would like to take this opportunity to thank Katherine for her excellent contribution since IPO. It has been an absolute pleasure working with her, and she leaves the business in fantastic shape.

I would also like to take this opportunity to welcome Emilie McCarthy3 as our new Chief Financial Officer, replacing Lucy Tilley. I congratulate Lucy and thank her for her outstanding contribution to MAB since she joined in 2015. We wish her every success in the future."

1 Includes a total of 204 advisers at 17 May 2024 who are advisers in directly authorised firms that use MAB's subsidiary, Auxilium, a specialist protection service provider, for protection. For directly authorised advisers the fees received by MAB represent the net income received by MAB as there are no commission payouts made by MAB. MAB's Later life advisers are now dual authorised and hence are included in the mainstream number.

2 UK Finance, product transfer lending figures not available until early June.

3 Emilie McCarthy was appointed as a Director of the Single Homeless Project on 15 May 2024.

 

Enquiries:

Mortgage Advice Bureau (Holdings) Plc

Tel: +44 (0) 1332 525007

 

Peter Brodnicki - Chief Executive Officer

Ben Thompson - Deputy Chief Executive Officer

Lucy Tilley - Chief Financial Officer

 

Nominated Adviser and Joint Broker:

Deutsche Numis

Stephen Westgate / Giles Rolls

 

+44 (0)20 7260 1000

Joint Broker:

Peel Hunt LLP

Andrew Buchanan / Oliver Jackson / Rob Parker

 

+44 (0) 20 7418 8900

Media Enquiries: investor.relations@mab.org.uk

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
AGMSEFEDFELSEFI
Date   Source Headline
1st Dec 20255:25 pmRNSDirectors' Shareholdings and PDMR notification
18th Nov 20252:11 pmRNSDirectors' Shareholdings and PDMR notification
14th Nov 20257:00 amRNSNotice of Capital Markets Day Update
7th Nov 20255:15 pmRNSHolding(s) in Company
4th Nov 20251:34 pmRNSDirector/PDMR Shareholding
16th Oct 202512:40 pmRNSDirector/PDMR Shareholding
16th Oct 202512:38 pmRNSGrant of Options, PDMR Dealing,Total Voting Rights
30th Sep 20254:43 pmRNSDirector/PDMR Shareholding
25th Sep 20254:30 pmRNSDirector/PDMR Shareholding
23rd Sep 20255:01 pmRNSBlock listing Interim Review
23rd Sep 20257:00 amRNSInterim Results
17th Sep 20252:30 pmRNSDirector/PDMR Shareholding
2nd Sep 20257:00 amRNS-RNotice of HY25 Results and Investor Presentation
29th Aug 20251:13 pmRNSDirector/PDMR Shareholding
27th Aug 20254:26 pmRNSHolding(s) in Company
21st Aug 20253:01 pmRNSDirector/PDMR Shareholding
31st Jul 202511:32 amRNSDirector/PDMR Shareholding
24th Jul 20257:00 amRNSTrading Update
22nd Jul 20255:59 pmRNSEBT Share Purchase
17th Jul 20259:46 amRNSDirector/PDMR Shareholding
16th Jul 20251:58 pmRNSHolding(s) in Company
9th Jul 20259:05 amRNS-RMAB Launches First-Time Buyer Campaign
3rd Jul 20259:54 amRNSDirector/PDMR Shareholding
27th Jun 20253:46 pmRNSNotification of major holdings
19th Jun 20257:00 amRNSBoard Changes
18th Jun 202510:55 amRNSDirector/PDMR Shareholding
11th Jun 202510:18 amRNSHolding(s) in Company
3rd Jun 20252:47 pmRNSDirector/PDMR Shareholding
30th May 20253:52 pmRNSDirector/PDMR Shareholding
22nd May 20257:00 amRNSResults of Annual General Meeting
21st May 20257:00 amRNSAGM Trading Statement
16th May 202512:30 pmRNSDirector/PDMR Shareholding
6th May 202512:37 pmRNSHolding(s) in Company
1st May 20255:19 pmRNSDirectors' Shareholdings and PDMR notification
30th Apr 20255:15 pmRNSGrant of Options, PDMR Dealing and TVR
29th Apr 20258:48 amRNSNotice of AGM
17th Apr 20251:40 pmRNSHolding(s) in Company
16th Apr 20259:58 amRNSDirector/PDMR Shareholding
10th Apr 20257:00 amRNSAppointment of Joint Corporate Broker
4th Apr 20257:10 amRNSAnnual Report and Notice of AGM
1st Apr 20253:51 pmRNSDirector/PDMR Shareholding
27th Mar 20259:18 amRNSHolding(s) in Company
19th Mar 20257:00 amRNSDirectorate Change
18th Mar 20257:00 amRNSFinal Results for the year ended 31 December 2024
17th Mar 20253:40 pmRNSDirector/PDMR Shareholding
14th Mar 20257:00 amRNSBlock Admission Application
5th Mar 202511:29 amRNSDirector/PDMR Shareholding
26th Feb 20257:00 amRNS-RNotice of Investor Presentation
18th Feb 20253:57 pmRNSDirector/PDMR Shareholding
17th Feb 20253:29 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.